Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Non-cash Items: 2020-2025

Historic Non-cash Items for Biodesix (BDSX) over the last 5 years, with Sep 2025 value amounting to $27,000.

  • Biodesix's Non-cash Items fell 97.84% to $27,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $27,000, marking a year-over-year decrease of 97.84%. This contributed to the annual value of $1.9 million for FY2024, which is 43.61% up from last year.
  • Latest data reveals that Biodesix reported Non-cash Items of $27,000 as of Q3 2025, which was down 99.02% from $2.8 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Non-cash Items registered a high of $37.7 million during Q1 2021, and its lowest value of $27,000 during Q3 2025.
  • Moreover, its 3-year median value for Non-cash Items was $1.4 million (2024), whereas its average is $1.4 million.
  • Per our database at Business Quant, Biodesix's Non-cash Items surged by 678.72% in 2021 and then slumped by 97.84% in 2025.
  • Biodesix's Non-cash Items (Quarterly) stood at $6.3 million in 2021, then tumbled by 76.32% to $1.5 million in 2022, then slumped by 35.26% to $964,000 in 2023, then soared by 93.36% to $1.9 million in 2024, then tumbled by 97.84% to $27,000 in 2025.
  • Its Non-cash Items was $27,000 in Q3 2025, compared to $2.8 million in Q2 2025 and $2.4 million in Q1 2025.